Cargando…
Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
Autores principales: | Gunosewoyo, Hendra, Kruger, Gert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465373/ https://www.ncbi.nlm.nih.gov/pubmed/36105235 http://dx.doi.org/10.3389/fphar.2022.997618 |
Ejemplares similares
-
Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023) -
Editorial: Drug-ability strategies for potential antimycobacterial candidate: opportunities and challenges
por: Swain, Shasank Sekhar, et al.
Publicado: (2023) -
Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022) -
Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics
por: Liu, Linsheng
Publicado: (2022) -
Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
por: Alsayed, Shahinda S. R., et al.
Publicado: (2023)